About
Miromatrix develops bioengineered human organs for transplantation using proprietary perfusion decellularization and recellularization technology that replaces pig cells with human cells to create transplantable organs.
Explore Miromatrix's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.